HK Stock MarketDetailed Quotes

JD HEALTH (06618)

Watchlist
  • 67.200
  • -0.700-1.03%
Not Open Jan 16 16:07 CST
215.66BMarket Cap41.66P/E (TTM)

JD HEALTH (06618) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
Turnover
24.51%35.29B
25.46%16.65B
8.65%58.16B
4.55%28.34B
-4.90%13.27B
14.54%53.53B
34.04%27.11B
--13.95B
52.32%46.74B
48.30%20.23B
Operating income
24.51%35.29B
8.65%58.16B
4.55%28.34B
14.54%53.53B
34.04%27.11B
52.32%46.74B
48.30%20.23B
Cost of sales
-21.97%-26.4B
----
-7.65%-44.85B
-3.52%-21.64B
----
-13.08%-41.66B
-32.24%-20.91B
----
-56.89%-36.84B
-53.05%-15.81B
Operating expenses
-21.97%-26.4B
-7.65%-44.85B
-3.52%-21.64B
-13.08%-41.66B
-32.24%-20.91B
-56.89%-36.84B
-53.05%-15.81B
Gross profit
32.72%8.89B
12.16%13.31B
8.01%6.7B
19.95%11.87B
40.51%6.2B
37.43%9.89B
33.47%4.41B
Selling expenses
-28.83%-1.81B
----
-14.83%-3.05B
-17.52%-1.4B
----
-20.91%-2.65B
-28.03%-1.19B
----
-2.90%-2.2B
4.59%-933.3M
Administrative expenses
10.74%-611.51M
----
28.99%-1.42B
21.87%-685.06M
----
7.20%-2B
11.09%-876.78M
----
15.12%-2.15B
12.17%-986.16M
Research and development expenses
-14.17%-736.39M
----
-8.47%-1.33B
-4.56%-645.02M
----
-14.93%-1.23B
-26.72%-616.86M
----
-19.52%-1.07B
-21.16%-486.8M
Impairment and provision
-633.00%-55.48M
----
-352.13%-315.85M
116.10%10.41M
----
28.86%-69.86M
-486.50%-64.66M
----
-156.05%-98.2M
-12.15%-11.03M
-Other impairment is provision
-633.00%-55.48M
----
-352.13%-315.85M
116.10%10.41M
----
28.86%-69.86M
-486.50%-64.66M
----
-156.05%-98.2M
-12.15%-11.03M
Operating interest expense
----
----
----
----
----
----
----
----
-51.68%-9.1M
-102.28%-4.87M
Special items of operating profit
-44.32%-3.58B
----
16.23%-4.26B
1.47%-2.48B
----
-42.40%-5.09B
-60.77%-2.52B
----
-49.19%-3.58B
-42.77%-1.57B
Operating profit
40.39%2.1B
119.78%1.07B
255.33%2.93B
60.48%1.49B
-38.74%487.32M
4.04%824.56M
118.67%931.36M
795.45M
198.17%792.57M
239.75%425.91M
Financing income
-18.29%808.56M
----
0.59%1.96B
5.67%989.51M
----
--1.95B
--936.46M
----
----
----
Financing cost
-3.66%-4.17M
----
13.61%-8.19M
8.34%-4.02M
----
---9.49M
---4.39M
----
----
----
Share of profits of associates
4.07%-39.15M
----
-20.87%-85.53M
-26.74%-40.81M
----
26.87%-70.76M
33.70%-32.2M
----
-2.75%-96.76M
-19.82%-48.57M
Earning before tax
17.40%2.86B
78.09%4.8B
33.21%2.44B
287.08%2.69B
385.29%1.83B
177.18%695.81M
209.28%377.35M
Tax
32.75%-272.32M
----
-16.20%-639.66M
-50.41%-404.96M
----
-76.10%-550.47M
-74.39%-269.23M
----
-82.45%-312.58M
-41.76%-154.39M
After-tax profit from continuing operations
27.38%2.59B
93.99%4.16B
30.24%2.03B
459.16%2.14B
600.58%1.56B
135.72%383.23M
149.09%222.96M
Earning after tax
27.38%2.59B
4.58%934.36M
93.99%4.16B
30.24%2.03B
893.43M
459.16%2.14B
600.58%1.56B
135.72%383.23M
149.09%222.96M
Minority profit
-81.81%-5.1M
----
-564.87%-4.83M
-542.27%-2.8M
----
-66.74%1.04M
206.73%634K
----
353.41%3.12M
-163.80%-594K
Profit attributable to shareholders
27.45%2.6B
94.31%4.16B
30.48%2.04B
463.49%2.14B
598.43%1.56B
135.41%380.11M
149.12%223.55M
Basic earnings per share
26.15%0.82
91.30%1.32
30.00%0.65
475.00%0.69
614.29%0.5
134.29%0.12
146.67%0.07
Diluted earnings per share
24.62%0.81
94.12%1.32
32.65%0.65
466.67%0.68
600.00%0.49
134.29%0.12
146.67%0.07
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
--
Unqualified Opinion
--
--
Unqualified Opinion
--
--
Unqualified Opinion
--
Auditor
--
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022
Turnover 24.51%35.29B25.46%16.65B8.65%58.16B4.55%28.34B-4.90%13.27B14.54%53.53B34.04%27.11B--13.95B52.32%46.74B48.30%20.23B
Operating income 24.51%35.29B8.65%58.16B4.55%28.34B14.54%53.53B34.04%27.11B52.32%46.74B48.30%20.23B
Cost of sales -21.97%-26.4B-----7.65%-44.85B-3.52%-21.64B-----13.08%-41.66B-32.24%-20.91B-----56.89%-36.84B-53.05%-15.81B
Operating expenses -21.97%-26.4B-7.65%-44.85B-3.52%-21.64B-13.08%-41.66B-32.24%-20.91B-56.89%-36.84B-53.05%-15.81B
Gross profit 32.72%8.89B12.16%13.31B8.01%6.7B19.95%11.87B40.51%6.2B37.43%9.89B33.47%4.41B
Selling expenses -28.83%-1.81B-----14.83%-3.05B-17.52%-1.4B-----20.91%-2.65B-28.03%-1.19B-----2.90%-2.2B4.59%-933.3M
Administrative expenses 10.74%-611.51M----28.99%-1.42B21.87%-685.06M----7.20%-2B11.09%-876.78M----15.12%-2.15B12.17%-986.16M
Research and development expenses -14.17%-736.39M-----8.47%-1.33B-4.56%-645.02M-----14.93%-1.23B-26.72%-616.86M-----19.52%-1.07B-21.16%-486.8M
Impairment and provision -633.00%-55.48M-----352.13%-315.85M116.10%10.41M----28.86%-69.86M-486.50%-64.66M-----156.05%-98.2M-12.15%-11.03M
-Other impairment is provision -633.00%-55.48M-----352.13%-315.85M116.10%10.41M----28.86%-69.86M-486.50%-64.66M-----156.05%-98.2M-12.15%-11.03M
Operating interest expense ---------------------------------51.68%-9.1M-102.28%-4.87M
Special items of operating profit -44.32%-3.58B----16.23%-4.26B1.47%-2.48B-----42.40%-5.09B-60.77%-2.52B-----49.19%-3.58B-42.77%-1.57B
Operating profit 40.39%2.1B119.78%1.07B255.33%2.93B60.48%1.49B-38.74%487.32M4.04%824.56M118.67%931.36M795.45M198.17%792.57M239.75%425.91M
Financing income -18.29%808.56M----0.59%1.96B5.67%989.51M------1.95B--936.46M------------
Financing cost -3.66%-4.17M----13.61%-8.19M8.34%-4.02M-------9.49M---4.39M------------
Share of profits of associates 4.07%-39.15M-----20.87%-85.53M-26.74%-40.81M----26.87%-70.76M33.70%-32.2M-----2.75%-96.76M-19.82%-48.57M
Earning before tax 17.40%2.86B78.09%4.8B33.21%2.44B287.08%2.69B385.29%1.83B177.18%695.81M209.28%377.35M
Tax 32.75%-272.32M-----16.20%-639.66M-50.41%-404.96M-----76.10%-550.47M-74.39%-269.23M-----82.45%-312.58M-41.76%-154.39M
After-tax profit from continuing operations 27.38%2.59B93.99%4.16B30.24%2.03B459.16%2.14B600.58%1.56B135.72%383.23M149.09%222.96M
Earning after tax 27.38%2.59B4.58%934.36M93.99%4.16B30.24%2.03B893.43M459.16%2.14B600.58%1.56B135.72%383.23M149.09%222.96M
Minority profit -81.81%-5.1M-----564.87%-4.83M-542.27%-2.8M-----66.74%1.04M206.73%634K----353.41%3.12M-163.80%-594K
Profit attributable to shareholders 27.45%2.6B94.31%4.16B30.48%2.04B463.49%2.14B598.43%1.56B135.41%380.11M149.12%223.55M
Basic earnings per share 26.15%0.8291.30%1.3230.00%0.65475.00%0.69614.29%0.5134.29%0.12146.67%0.07
Diluted earnings per share 24.62%0.8194.12%1.3232.65%0.65466.67%0.68600.00%0.49134.29%0.12146.67%0.07
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions ----Unqualified Opinion----Unqualified Opinion----Unqualified Opinion--
Auditor ----Deloitte Guan Huang Chen Fang Certified Public Accountants----Deloitte Guan Huang Chen Fang Certified Public Accountants----Deloitte Guan Huang Chen Fang Certified Public Accountants--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
View More
New Consumption Stocks
View More
Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.
Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde Show More